Clinical trials need a matchmaker. Healthcare researchers and pharmaceutical companies rely on trials to validate new, potentially life-saving therapies for cancer and other serious conditions. But fewer than 10 percent of cancer patients participate in clinical trials, and four out of five studies are delayed due to the challenges involved in recruiting participants. For patients Read article >
The post Meet Your Match: AI Finds the Right Clinical Trial for Cancer Patients appeared first on The Official NVIDIA Blog.
- View Press Release
- Visit NVIDIA Corporation